HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California’s Toxic Free Cosmetics Act And The Case For Iconclad Federal Preemption

Executive Summary

Limited to no federal preemption is included in cosmetics bills under consideration in the 116th Congress, which means that even if one were to pass in its current form, companies could still be at the mercy of states, typically California, imposing unique bans or restrictions on cosmetic ingredients.

Advertisement

Related Content

ICMAD: Federal Cosmetics Legislation Without National Uniformity Not In Industry’s Interest
Toxic Free Cosmetics Act Underscores Question: Who Should Regulate US Market, FDA Or California?
Toxic Free Cosmetics Act Underscores Question: Who Should Regulate US Market, FDA Or California?
Rep. Pallone’s Discussion Draft For Cosmetics Reform Closely Mirrors Reintroduced Feinstein/Collins Bill
FDA Determined To Update Cosmetics Regs After Claire’s Refuses To Recall Asbestos-Tainted Makeup
2018 In Review: California, Hawaii Pass Personal-Care Legislation Among 300+ State Bills Overall
Rep. Pallone Has Cosmetics Concerns, Possibly Coming To A Storefront Near You
Surprise Hatch Bill Lays Middle Ground For Cosmetic Regulatory Reform
FDA Questions Constitutionality Of Proposed CIR Bridge, A Blow To CMA Bill
PCPSA's 'No Harm' Standard Would Set High Bar For FDA Ingredient Review

Topics

Advertisement
UsernamePublicRestriction

Register

RS148680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel